Cargando…
Faecal Myeloperoxidase as a Biomarker of Endoscopic Activity in Inflammatory Bowel Disease
BACKGROUND AND AIMS: Inflammatory bowel disease [IBD], consisting of Crohn’s disease [CD] and ulcerative colitis [UC], is a relapsing-remitting illness. Treat-to-target IBD management strategies require monitoring of gastrointestinal inflammation. This study aimed to investigate faecal myeloperoxida...
Autores principales: | Swaminathan, Akhilesh, Borichevsky, Grace M, Edwards, Teagan S, Hirschfeld, Esther, Mules, Thomas C, Frampton, Chris M A, Day, Andrew S, Hampton, Mark B, Kettle, Anthony J, Gearry, Richard B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721461/ https://www.ncbi.nlm.nih.gov/pubmed/35803583 http://dx.doi.org/10.1093/ecco-jcc/jjac098 |
Ejemplares similares
-
The Impact of Disease Activity on Sexual and Erectile Dysfunction in Patients With Inflammatory Bowel Disease
por: Mules, Thomas C, et al.
Publicado: (2022) -
The disease severity index for inflammatory bowel disease is associated with psychological symptoms and quality of life, and predicts a more complicated disease course
por: Swaminathan, Akhilesh, et al.
Publicado: (2022) -
A myeloperoxidase precursor, pro-myeloperoxidase, is present in human plasma and elevated in cardiovascular disease patients
por: Khalilova, Irada S., et al.
Publicado: (2018) -
Inactivation of human myeloperoxidase by hydrogen peroxide()
por: Paumann-Page, Martina, et al.
Publicado: (2013) -
Inflammatory Bowel Disease in Australasian Children and Adolescents
por: Day, A. S., et al.
Publicado: (2014)